Kazakhstan has reported a decline in acute respiratory viral infections. A total of 74,689 cases were registered from October 22 to 28, down 44% from the same period of the previous epidemic season and 1.5 times lower than the week before.
Since the start of the epidemic season, 1,075,450 cases have been recorded, 4.7% fewer than during the same period last year.
Laboratory monitoring shows that rhinoviruses, adenoviruses and bocaviruses are the most prevalent non-influenza viruses. Twelve cases of influenza A(H1N1)pdm09 have been laboratory-confirmed since the season began.
Flu vaccination is continuing across the country. Kazakhstan has procured 2.2 million doses of Grippol®, enough to vaccinate about 11% of the population. The vaccine is available in all regions.
As of October 30, 1,670,447 people had been vaccinated, equal to 75.3% of those eligible for vaccination.
During the respiratory infection season, people are advised to wash their hands frequently, especially after visiting public places, air rooms regularly and follow respiratory etiquette. Those who develop symptoms should limit contact with others where possible and seek medical care if they have a high temperature, their condition worsens or symptoms are severe.
